Prognostic utility of gamma-glutamyl transpeptidase to platelet ratio in patients with solitary hepatitis B virus-related hepatocellular carcinoma after hepatectomy

doi:10.4251/wjgo.v16.i12.4579

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 12

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1284)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-6) series, Tables (1-4) series.

Item

Count

PDF

HTML

584

Figures (1-6)

119

Tables (1-4)

107

Sum=836

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

104

Download

176

Sum=280

Publishing Process of This Article

Item

Count

Browse

Download

101

Sum=129

Dec 15, 2024 (publication date) through Feb 15, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Control Study

World J Gastrointest Oncol. Dec 15, 2024; 16(12): 4579-4596
Published online Dec 15, 2024. doi: 10.4251/wjgo.v16.i12.4579

Prognostic utility of gamma-glutamyl transpeptidase to platelet ratio in patients with solitary hepatitis B virus-related hepatocellular carcinoma after hepatectomy

Cheng-Kun Yang, Zhong-Liu Wei, Xiao-Qiang Shen, Yu-Xuan Jia, Qiong-Yuan Wu, Yong-Guang Wei, Hao Su, Wei Qin, Xi-Wen Liao, Guang-Zhi Zhu, Tao Peng

Cheng-Kun Yang, Zhong-Liu Wei, Xiao-Qiang Shen, Yu-Xuan Jia, Yong-Guang Wei, Hao Su, Wei Qin, Xi-Wen Liao, Guang-Zhi Zhu, Tao Peng, Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, China

Cheng-Kun Yang, Zhong-Liu Wei, Xiao-Qiang Shen, Yu-Xuan Jia, Yong-Guang Wei, Hao Su, Wei Qin, Xi-Wen Liao, Guang-Zhi Zhu, Tao Peng, Guangxi Key Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer, Nanning 530021, Guangxi Zhuang Autonomous Region, China

Qiong-Yuan Wu, Department of Tuina, Nanning Hospital of Traditional Chinese Medicine, Nanning 530022, Guangxi Zhuang Autonomous Region, China

Author contributions: Yang CK and Peng T designed the study; Yang CK, Wei ZL, Shen XQ, Jia YX, and Wu QY performed research; Yang CK, Wei ZL, Shen XQ, Jia YX, Wu QY and Wei XL provided sample collection and clinical support; Yang CK, Wei YG, Su H, Liao XW, Zhu GZ and Qin W contributed to data interpretation; Yang CK and Wei ZL wrote the manuscript; Peng T critically revised the manuscript and participated in the analysis and interpretation of the data; all of the authors read and approved the final version of the manuscript to be published.

Supported by The National Natural Science Foundation of China, No. 81560535, No. 81802874 and No. 81072321; and The Self-funded Scientific Research Project of Health Commission in Guangxi Zhuang Autonomous Region, China, No. Z20210977.

Institutional review board statement: This study was approved by The Ethics Committee of The First Affiliated Hospital of Guangxi Medical University, China.

Informed consent statement: All participants signed written informed consent before study commencement.

Conflict-of-interest statement: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Data sharing statement: The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

STROBE statement: The authors have read the STROBE Statement-checklist of items, and the manuscript was prepared and revised according to the STROBE Statement-checklist of items.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Tao Peng, MD, PhD, Professor, Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, No. 6 Shuangyong Road, Nanning 530021, Guangxi Zhuang Autonomous Region, China. pengtaogmu@163.com

Received: February 28, 2024
Revised: September 12, 2024
Accepted: September 29, 2024
Published online: December 15, 2024
Processing time: 258 Days and 2.4 Hours

Core Tip

Core Tip: In this study, we assessed the prognostic value of gamma-glutamyl transpeptidase to platelet ratio (GPR) in early hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) patients. We evaluated the clinical utility of preoperative GPR in predicting outcomes for solitary HBV-related HCC patients using propensity score matching, restricted cubic spline, survival analyses and stratified analyses. Preoperative GPR levels facilitate recurrence monitoring and inform treatment strategies, potentially enhancing the quality of life for HCC patients.